GB0916723D0 - A method for preparing antigens of foot-and-mouth disease virus - Google Patents

A method for preparing antigens of foot-and-mouth disease virus

Info

Publication number
GB0916723D0
GB0916723D0 GBGB0916723.0A GB0916723A GB0916723D0 GB 0916723 D0 GB0916723 D0 GB 0916723D0 GB 0916723 A GB0916723 A GB 0916723A GB 0916723 D0 GB0916723 D0 GB 0916723D0
Authority
GB
United Kingdom
Prior art keywords
foot
disease virus
mouth disease
preparing antigens
antigens
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
GBGB0916723.0A
Other versions
GB2463783B (en
GB2463783A (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Biotechnology Research Institute of CAAS
Lanzhou Veterinary Research Institute of CAAS
Original Assignee
Biotechnology Research Institute of CAAS
Lanzhou Veterinary Research Institute of CAAS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biotechnology Research Institute of CAAS, Lanzhou Veterinary Research Institute of CAAS filed Critical Biotechnology Research Institute of CAAS
Publication of GB0916723D0 publication Critical patent/GB0916723D0/en
Publication of GB2463783A publication Critical patent/GB2463783A/en
Application granted granted Critical
Publication of GB2463783B publication Critical patent/GB2463783B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/125—Picornaviridae, e.g. calicivirus
    • A61K39/135—Foot- and mouth-disease virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C07K14/08—RNA viruses
    • C07K14/085—Picornaviridae, e.g. coxsackie virus, echovirus, enterovirus
    • C07K14/09—Foot-and-mouth disease virus
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • C12N15/866—Baculoviral vectors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/14011—Baculoviridae
    • C12N2710/14111—Nucleopolyhedrovirus, e.g. autographa californica nucleopolyhedrovirus
    • C12N2710/14141—Use of virus, viral particle or viral elements as a vector
    • C12N2710/14143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/32011—Picornaviridae
    • C12N2770/32111—Aphthovirus, e.g. footandmouth disease virus
    • C12N2770/32122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Immunology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
GB0916723.0A 2007-03-23 2008-01-17 A method for preparing foot-and-mouth disease virus antigens Active GB2463783B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN2007100900359A CN101121938B (en) 2007-03-23 2007-03-23 Method for preparing foot-and-mouth disease antigen
PCT/CN2008/000126 WO2008116368A1 (en) 2007-03-23 2008-01-17 A method for preparing antigens of foot-and-mouth disease virus

Publications (3)

Publication Number Publication Date
GB0916723D0 true GB0916723D0 (en) 2009-11-04
GB2463783A GB2463783A (en) 2010-03-31
GB2463783B GB2463783B (en) 2013-01-09

Family

ID=39084436

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0916723.0A Active GB2463783B (en) 2007-03-23 2008-01-17 A method for preparing foot-and-mouth disease virus antigens

Country Status (3)

Country Link
CN (1) CN101121938B (en)
GB (1) GB2463783B (en)
WO (1) WO2008116368A1 (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101121938B (en) * 2007-03-23 2010-10-06 中国农业科学院兰州兽医研究所 Method for preparing foot-and-mouth disease antigen
KR101851699B1 (en) 2009-11-02 2018-04-24 더 트러스티스 오브 더 유니버시티 오브 펜실바니아 Foot and mouth disease virus (fmdv) consensus proteins, coding sequences therefor and vaccines made therefrom
CN101812120A (en) * 2010-02-10 2010-08-25 中国检验检疫科学研究院 South Africa II type foot-and-mouth disease epitope polypeptide and screening method thereof
BR112012023852B1 (en) * 2010-03-12 2020-11-10 Biolex Therapeutics recombinant blue tongue virus vaccines and their uses
CN101816297B (en) * 2010-04-30 2011-07-20 中国计量学院 Method for trapping, preventing and controlling adults of ectropis obliqua
CN102311957B (en) * 2010-07-09 2014-03-12 中国农业科学院生物技术研究所 Hydatidovis soluble antigen preparation method and product thereof
CN102533860B (en) * 2012-01-10 2013-07-24 特菲(天津)生物医药科技有限公司 Foot and mouth disease vaccine and preparation method thereof
CN114045295A (en) 2013-03-15 2022-02-15 宾夕法尼亚大学理事会 Foot and Mouth Disease Virus (FMDV) consensus proteins, coding sequences thereof, and vaccines made therefrom
EP2845904A1 (en) * 2013-09-06 2015-03-11 Ceva Sante Animale Recombinant Marek's disease viruses and uses thereof
US10435695B2 (en) 2016-09-08 2019-10-08 The Government of the United States of America, as represented by the Secretary of Homeland Security Fusion protein comprising Gaussia luciferase, translation interrupter sequence, and interferon amino acid sequences
US10385319B2 (en) * 2016-09-08 2019-08-20 The Governement of the United States of America, as represented by the Secretary of Homeland Security Modified foot-and-mouth disease virus 3C proteases, compositions and methods thereof

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4769237A (en) * 1983-03-25 1988-09-06 Bittle James L Synthetic picornavirus antigen
AU4197389A (en) * 1988-08-05 1990-03-05 Mount Sinai School Of Medicine Of The City University Of New York, The In vivo infection of live insects with a recombinant baculovirus
US7217784B2 (en) * 2003-05-29 2007-05-15 Academia Sinica VP1 of foot-and-mouth disease virus
KR100737446B1 (en) * 2004-11-23 2007-07-09 대한민국 Recombinant Baculovirus Comprising Genes Coding Structural Proteins of FMDV and Production Method of Recombinant Protein
CN100425291C (en) * 2005-04-06 2008-10-15 中国农业科学院兰州兽医研究所 O-type foot-and-mouth disease virus poly-gene duplication defect type adenovirus active carrier vaccine and process for preparing the same
CN101121938B (en) * 2007-03-23 2010-10-06 中国农业科学院兰州兽医研究所 Method for preparing foot-and-mouth disease antigen

Also Published As

Publication number Publication date
CN101121938A (en) 2008-02-13
CN101121938B (en) 2010-10-06
WO2008116368A1 (en) 2008-10-02
GB2463783B (en) 2013-01-09
GB2463783A (en) 2010-03-31

Similar Documents

Publication Publication Date Title
GB0916723D0 (en) A method for preparing antigens of foot-and-mouth disease virus
SG10201404101RA (en) Method For Producing Viral Vaccines
ZA201001480B (en) Method for producing flu virus
IL237406A0 (en) Improved methods for producing yeast-based vaccines
EP2351581A4 (en) A vaccine composition against foot-and-mouth disease and the preparation method thereof
IL203428A (en) Method for preparing a vitreous composition comprising an antigen
GB0700136D0 (en) Process for manufacturing vaccines
HK1144440A1 (en) Hepatitis c virus antibodies
HK1158628A1 (en) Process for preparing dihydropteridinone derivatives
GB0822068D0 (en) Methods for virus design
EP1848679A4 (en) Method for preparing trimethylolpropane
PL2213654T3 (en) Process for preparing 2-amino-5-bromobenzamide derivatives
ZA201004531B (en) Method for producing vaccinal viral strain of a virus of the reoviridae family
GB0614133D0 (en) Process for preparing a pharmaceutical compound
EP1871411A4 (en) Expressing hepatitis b virus surface antigen for vaccine preparation
EP2052082A4 (en) Chimeric newcastle disease virus vlps
EP2351835A4 (en) Method for producing purified influenza virus antigen
HK1111160A1 (en) Process for preparing
HK1119692A1 (en) Process for preparing tetramethylglycolide
HK1147773A1 (en) West nile virus vaccine, and method for production thereof
ZA200907695B (en) Process for preparing dorzolam ide
EP2226335A4 (en) Method for producing methyl cellulose
EP2088431A4 (en) METHOD FOR ANALYSIS OF HEPATITIS B VIRUS s ANTIGEN
IL195262A0 (en) Process for preparing hydroxylpatite
GB0612695D0 (en) Process for preparing a solid dosage form

Legal Events

Date Code Title Description
789A Request for publication of translation (sect. 89(a)/1977)

Ref document number: 2008116368

Country of ref document: WO

R108 Alteration of time limits (patents rules 1995)

Free format text: EXTENSION ALLOWED

Effective date: 20120723

Free format text: EXTENSION APPLICATION

Effective date: 20120627

R108 Alteration of time limits (patents rules 1995)

Free format text: EXTENSION ALLOWED

Effective date: 20120923

Free format text: EXTENSION APPLICATION

Effective date: 20120921